Award recordCONTRACT

BAYER HEALTHCARE PHARMACEUTICALS INC

PIID 36C24721F0522· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $1,134,224 net obligations· UEI V1EVGCK7XES8· NJ

Description

XOFIGO

First action · last action
2021-07-02 · 2024-03-27
Transactions
3
First transaction's obligation
$556,819
Base + all options value (sum of deltas)
$1,134,224
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0237
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,309,059$0Base award · 2021-07-02 · this action $556,819 · running total $556,819Modification P00001 · 2022-05-23 · this action $752,240 · running total $1,309,059Modification P00003 · 2024-03-27 · this action -$174,836 · running total $1,134,224
  • Base2021-07-02+$556,819= $556,819
  • Mod P000012022-05-23+$752,240= $1,309,059
  • Mod P000032024-03-27-$174,836= $1,134,224
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-07-02+$556,819$556,819XOFIGO
Mod P00001· EXERCISE AN OPTION2022-05-23+$752,240$1,309,059XOFIGO
Mod P00003· OTHER ADMINISTRATIVE ACTION2024-03-27−$174,836$1,134,224XOFIGO

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V1EVGCK7XES8)

AwardOffice · PSC / listingNet obligationsFY
36C25626N0492256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$386,860FY2026
36C26226F0163262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$181,386FY2026
36C26026F0086260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$80,663FY2026
36C26126N0199261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$101,567FY2026
36C25626N0126256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$214,783FY2026
36E79725A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24721F0522_3600_36F79720D0237_3600 · retrieved 2026-09-26.